|
1
|
NCD Risk Factor Collaboration (NCD-RisC):
Worldwide trends in diabetes since 1980: A pooled analysis of 751
population-based studies with 4.4 million participants. Lancet.
387:1513–1530. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Shan Y, Li Y, Luo X and Shi H:
Palmitate impairs angiogenesis via suppression of cathepsin
activity. Mol Med Rep. 15:3644–3650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Farmer JA: Diabetic dyslipidemia and
atherosclerosis: Evidence from clinical trials. Curr Diab Rep.
8:71–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Listenberger LL, Han X, Lewis SE, Cases S,
Farese RV Jr, Ory DS and Schaffer JE: Triglyceride accumulation
protects against fatty acid-induced lipotoxicity. Proc Natl Acad
Sci USA. 100:3077–3082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo WX, Yang QD, Liu YH, Xie XY, Wang M
and Niu RC: Palmitic and linoleic acids impair endothelial
progenitor cells by inhibition of Akt/eNOS pathway. Arch Med Res.
39:434–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Devanesan AJ, Laughlan KA, Girn HRS and
Homer-Vanniasinkam S: Endothelial progenitor cells as a therapeutic
option in peripheral arterial disease. Eur J Vasc Endovasc Surg.
38:475–481. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Asahara T, Masuda H, Takahashi T, Kalka C,
Pastore C, Silver M, Kearne M, Magner M and Isner JM: Bone marrow
origin of endothelial progenitor cells responsible for postnatal
vasculo-genesis in physiological and pathological
neovascularization. Circ Res. 85:221–228. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Egan CG, Lavery R, Caporali F, Fondelli C,
Laghi-Pasini F, Dotta F and Sorrentino V: Generalised reduction of
putative endothelial progenitors and CXCR4-positive peripheral
blood cells in type 2 diabetes. Diabetologia. 51:1296–1305. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Loomans CJ, de Koning EJ, Staal FJ,
Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B,
Rabelink TJ and van Zonneveld AJ: Endothelial progenitor cell
dysfunction: A novel concept in the pathogenesis of vascular
complications of type 1 diabetes. Diabetes. 53:195–199. 2004.
View Article : Google Scholar
|
|
11
|
Tepper OM, Galiano RD, Capla JM, Kalka C,
Gagne PJ, Jacobowitz GR, Levine JP and Gurtner GC: Human
endothelial progenitor cells from type II diabetics exhibit
impaired proliferation, adhesion, and incorporation into vascular
structures. Circulation. 106:2781–2786. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Barthelmes D, Irhimeh MR, Gillies MC,
Karimipour M, Zhou M, Zhu L and Shen WY: Diabetes impairs
mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+)
progenitor cells. Blood Cells Mol Dis. 51:163–173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trombetta A, Togliatto G, Rosso A,
Dentelli P, Olgasi C, Cotogni P and Brizzi MF: Increase of palmitic
acid concentration impairs endothelial progenitor cell and bone
marrow-derived progenitor cell bioavailability: Role of the
STAT5/PPARgamma transcriptional complex. Diabetes. 62:1245–1257.
2013. View Article : Google Scholar :
|
|
14
|
Badr G, Hozzein WN, Badr BM, Al Ghamdi A,
Saad Eldien HM and Garraud O: Bee venom accelerates wound healing
in diabetic mice by suppressing activating transcription factor-3
(ATF-3) and inducible nitric oxide synthase (iNOS)-mediated
oxidative stress and recruiting bone marrow-derived endothelial
progenitor cells. J Cell Physiol. 231:2159–2171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Abplanalp WT, Conklin DJ, Cantor JM,
Ginsberg MH, Wysoczynski M, Bhatnagar A and O'Toole TE: Enhanced
integrin α4β1-mediated adhesion contributes to a mobilization
defect of endothelial progenitor cells in diabetes. Diabetes.
65:3505–3515. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qu K, Wang Z, Lin XL, Zhang K, He XL and
Zhang H: MicroRNAs: Key regulators of endothelial progenitor cell
functions. Clin Chim Acta. 448:65–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ye M, Li D, Yang J, Xie J, Yu F, Ma Y, Zhu
X, Zhao J and Lv Z: MicroRNA-130a targets MAP3K12 to modulate
diabetic endothelial progenitor cell function. Cell Physiol
Biochem. 36:712–726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song MS, Carracedo A, Salmena L, Song SJ,
Egia A, Malumbres M and Pandolfi PP: Nuclear PTEN regulates the
APC-CDH1 tumor-suppressive complex in a phosphatase-independent
manner. Cell. 144:187–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shiojima I and Walsh K: Role of Akt
signaling in vascular homeostasis and angiogenesis. Circ Res.
90:1243–1250. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song CL, Liu B, Shi YF, Liu N, Yan YY,
Zhang JC, Xue X, Wang JP, Zhao Z, Liu JG, et al: MicroRNA-130a
alleviates human coronary artery endothelial cell injury and
inflammatory responses by targeting PTEN via activating
PI3K/Akt/eNOS signaling pathway. Oncotarget. 7:71922–71936. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu JW, Deng YP, Han X, Ren GF, Cai J and
Jiang GJ: Metformin improves the angiogenic functions of
endothelial progenitor cells via activating AMPK/eNOS pathway in
diabetic mice. Cardiovasc Diabetol. 15:882016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arunachalam G, Lakshmanan AP, Samuel SM,
Triggle CR and Ding H: Molecular interplay between microRNA-34a and
Sirtuin1 in hyperglycemia-mediated impaired angiogenesis in
endothelial cells: Effects of metformin. J Pharmacol Exp Ther.
356:314–323. 2016. View Article : Google Scholar
|
|
25
|
Zhang Y, Chen F and Wang L: Metformin
inhibits development of diabetic retinopathy through
microRNA-497a-5p. Am J Transl Res. 9:5558–5566. 2017.
|
|
26
|
Dai X, Tan Y, Cai S, Xiong X, Wang L, Ye
Q, Yan X, Ma K and Cai L: The role of CXCR7 on the adhesion,
proliferation and angiogenesis of endothelial progenitor cells. J
Cell Mol Med. 15:1299–1309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brandl A, Yuan Q, Boos AM, Beier JP,
Arkudas A, Kneser U, Horch RE and Bleiziffer O: A novel early
precursor cell population from rat bone marrow promotes
angiogenesis in vitro. BMC Cell Biol. 15:122014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dai X, Yan X, Zeng J, Chen J, Wang Y, Chen
J, Li Y, Barati MT, Wintergerst KA, Pan K, et al: Elevating CXCR7
improves angiogenic function of EPCs via Akt/GSK-3beta/Fyn-mediated
Nrf2 activation in diabetic limb ischemia. Circ Res. 120:e7–e23.
2017. View Article : Google Scholar
|
|
29
|
Yan X, Cai S, Xiong X, Sun W, Dai X, Chen
S, Ye Q, Song Z, Jiang Q and Xu Z: Chemokine receptor CXCR7
mediates human endothelial progenitor cells survival, angiogenesis,
but not proliferation. J Cell Biochem. 113:1437–1446. 2012.
View Article : Google Scholar
|
|
30
|
Unseld M, Chilla A, Pausz C, Mawas R,
Breuss J, Zielinski C, Schabbauer G and Prager GW: PTEN expression
in endothelial cells is down-regulated by uPAR to promote
angiogenesis. Thromb Haemost. 114:379–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
32
|
Yu S, Li Z, Zhang W, Du Z, Liu K, Yang D
and Gong S: Isolation and characterization of endothelial
colony-forming cells from mononuclear cells of rat bone marrow. Exp
Cell Res. 370:116–126. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M
and Lv Z: Increased expression of microRNA-221 inhibits PAK1 in
endothelial progenitor cells and impairs its function via
c-Raf/MEK/ERK pathway. Biochem Biophys Res Commun. 431:404–408.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Che F, Du H, Zhang W, Cheng Z and Tong Y:
MicroRNA-132 modifies angiogenesis in patients with ischemic
cerebrovascular disease by suppressing the NFkappaB and VEGF
pathway. Mol Med Rep. 17:2724–2730. 2018.
|
|
35
|
Ambasta RK, Kohli H and Kumar P: Multiple
therapeutic effect of endothelial progenitor cell regulated by
drugs in diabetes and diabetes related disorder. J Transl Med.
15:1852017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fadini GP, Miorin M, Facco M, Bonamico S,
Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A,
Agostini C and Avogaro A: Circulating endothelial progenitor cells
are reduced in peripheral vascular complications of type 2 diabetes
mellitus. J Am Coll Cardiol. 45:1449–1457. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh
W, Sung J, Jeon ES, Oh HY and Kim DK: Decreased number and impaired
angiogenic function of endothelial progenitor cells in patients
with chronic renal failure. Arterioscler Thromb Vasc Biol.
24:1246–1252. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song X, Yang B, Qiu F, Jia M and Fu G:
High glucose and free fatty acids induce endothelial progenitor
cell senescence via PGC-1alpha/SIRT1 signaling pathway. Cell Biol
Int. 41:1146–1159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ke J, Wei R, Yu F, Zhang J and Hong T:
Liraglutide restores angiogenesis in palmitate-impaired human
endothelial cells through PI3K/Akt-Foxo1-GTPCH1 pathway. Peptides.
86:95–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Han X, Tao Y, Deng Y, Yu J, Sun Y and
Jiang G: Metformin accelerates wound healing in type 2 diabetic
db/db mice. Mol Med Rep. 16:8691–8698. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li WD, Li NP, Song DD, Rong JJ, Qian AM
and Li XQ: Metformin inhibits endothelial progenitor cell migration
by decreasing matrix metalloproteinases, MMP-2 and MMP-9, via the
AMPK/mTOR/autophagy pathway. Int J Mol Med. 39:1262–1268. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ashinuma H, Takiguchi Y, Kitazono S,
Kitazono-Saitoh M, Kitamura A, Chiba T, Tada Y, Kurosu K, Sakaida
E, Sekine I, et al: Antiproliferative action of metformin in human
lung cancer cell lines. Oncol Rep. 28:8–14. 2012.PubMed/NCBI
|
|
44
|
Kato K, Gong J, Iwama H, Kitanaka A, Tani
J, Miyoshi H, Nomura K, Mimura S, Kobayashi M, Aritomo Y, et al:
The anti-diabetic drug metformin inhibits gastric cancer cell
proliferation in vitro and in vivo. Mol Cancer Ther. 11:549–560.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han J, Li Y, Liu X, Zhou T, Sun H, Edwards
P, Gao H, Yu FS and Qiao X: Metformin suppresses retinal
angiogenesis and inflammation in vitro and in vivo. PLoS One.
13:e01930312018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang HH, Zhang Y, Cheng YN, Gong FL, Cao
ZQ, Yu LG and Guo XL: Metformin incombination with curcumin
inhibits the growth, metastasis, and angiogenesis of hepatocellular
carcinoma in vitro and in vivo. Mol Carcinog. 57:44–56. 2018.
View Article : Google Scholar
|
|
47
|
Yang Y, Jin G, Liu H, Liu K, Zhao J, Chen
X, Wang D, Bai R, Li X, Jang Y, et al: Metformin inhibits
esophageal squamous cell carcinoma-induced angiogenesis by
suppressing JAK/STAT3 signaling pathway. Oncotarget. 8:74673–74687.
2017.PubMed/NCBI
|
|
48
|
Wang N, Chen C, Yang D, Liao Q, Luo H,
Wang X, Zhou F, Yang X, Yang J, Zeng C and Wang WE: Mesenchymal
stem cells-derived extracellular vesicles, via miR-210, improve
infarcted cardiac function by promotion of angiogenesis. Biochim
Biophys Acta Mol Basis Dis. 1863:2085–2092. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liang L, Zhao L, Zan Y, Zhu Q, Ren J and
Zhao X: MiR-93-5p enhances growth and angiogenesis capacity of
HUVECs by down-regulating EPLIN. Oncotarget. 8:107033–107043. 2017.
View Article : Google Scholar :
|
|
50
|
Duan J, Zhang H, Qu Y, Deng T, Huang D,
Liu R, Zhang L, Bai M, Zhou L, Ying G and Ba Y: Onco-miR-130
promotes cell proliferation and migration by targeting TGFbetaR2 in
gastric cancer. Oncotarget. 7:44522–44533. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liang H, Yang K, Xin M, Liu X, Zhao L, Liu
B and Wang J: MiR-130a protects against lipopolysaccharide-induced
glomerular cell injury by upregulation of klotho. Pharmazie.
72:468–474. 2017.
|
|
52
|
Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo
J, Li HM, Zhang WS, Chen CY and Xie H: Exosomes from human
umbilical cord blood accelerate cutaneous wound healing through
miR-21-3p-mediated promotion of angiogenesis and fibroblast
function. Theranostics. 8:169–184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zheng Y, Liu L, Chen C, Ming P, Huang Q,
Li C, Cao D, Xu X and Ge W: The extracellular vesicles secreted by
lung cancer cells in radiation therapy promote endothelial cell
angiogenesis by transferring miR-23a. PeerJ. 5:e36272017.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wang DF, Yang HJ, Gu JQ, Cao YL, Meng X,
Wang XL, Lin YC and Gao M: Suppression of phosphatase and tensin
homolog protects insulin-resistant cells from apoptosis. Mol Med
Rep. 12:2695–2700. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Deng Y and Ma W: Metformin inhibits hacat
cell viability via the miR-21/PTEN/Akt signaling pathway. Mol Med
Rep. 17:4062–4066. 2018.
|
|
56
|
Gao F, Wang FG, Liu RR, Xue F, Zhang J, Xu
GQ, Bi JH, Meng Z and Huo R: Epigenetic silencing of miR-130a
ameliorates hemangioma by targeting tissue factor pathway inhibitor
2 through FAK/PI3K/Rac1/mdm2 signaling. Int J Oncol. 50:1821–1831.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jiang H, Yu WW, Wang LL and Peng Y:
MiR-130a acts as a potential diagnostic biomarker and promotes
gastric cancer migration, invasion and proliferation by targeting
RUNX3. Oncol Rep. 34:1153–1161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Oudit GY, Sun H, Kerfant BG, Crackower MA,
Penninger JM and Backx PH: The role of phosphoinositide-3 kinase
and PTEN in cardiovascular physiology and disease. J Mol Cell
Cardiol. 37:449–471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Cen M, Hu P, Cai Z, Fang T, Zhang J and Lu
M: TIEG1 defi-ciency confers enhanced myocardial protection in the
infarcted heart by mediating the Pten/Akt signalling pathway. Int J
Mol Med. 39:569–578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nip H, Dar AA, Saini S, Colden M, Varahram
S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, et al:
Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Oncotarget. 7:68371–68384. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yu L, Li Z, Dong X, Xue X, Liu Y, Xu S,
Zhang J, Han J, Yang Y and Wang H: Polydatin protects diabetic
heart against ischemia-reperfusion injury via Notch1/Hes1-mediated
activation of Pten/Akt signaling. Oxid Med Cell Longev.
2018:27506952018. View Article : Google Scholar : PubMed/NCBI
|
